Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Protocol for Postmenopausal Women at Increased Risk of Developing Breast Cancer

This study is ongoing, but not recruiting participants.
Intergenetics, Inc.
Information provided by (Responsible Party):
Carol Fabian, MD, University of Kansas Medical Center Identifier:
First received: May 19, 2006
Last updated: February 13, 2017
Last verified: February 2017
A study to examine the potential associations between common single nucleotide polymorphisms and pre-cancerous conditions in breast tissue specimens from postmenopausal women.

Condition Intervention
Breast Cancer
Procedure: Fine needle aspiration

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Correlation of SNP Patterns With Fine Needle Aspiration Cytomorphology in High Risk Postmenopausal Women

Resource links provided by NLM:

Further study details as provided by University of Kansas Medical Center:

Primary Outcome Measures:
  • Correlation of SNP patterns with cytlomorphology of breast fine needle aspirates. [ Time Frame: ongoing ]
    develoment of algorithm for prediction of risk of developing breast cancer.

Biospecimen Retention:   Samples With DNA
Fine needle aspirate

Estimated Enrollment: 500
Study Start Date: May 2005
Estimated Study Completion Date: November 2017
Estimated Primary Completion Date: November 2017 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Post-menopausal women who are at increased risk for development of breast cancer on the basis of family or personal history.
Procedure: Fine needle aspiration
Fine needle aspiration

Detailed Description:
A study to examine the correlation between single nucleotide polymorphisms (SNPs) affecting steroid and carcinogen metabolism and benign breast tissue cytomorphology collected via random periareolar fine needle aspiration in postmenopausal women at increased risk for breast cancer and taking hormone replacement therapy.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Post menopausal women, on or off hormone replacement therapy, at high risk of developing breast cancer

Inclusion Criteria:

  • postmenopausal women on or off hormone replacement therapy
  • at high risk of developing breast cancer determined by family or personal history
  • postmenopausal women not on hormone replacement therapy for at minimum six months prior to corresponding aspiration
  • willing to participate in companion protocol (KUMC HSC#4601) for random periareolar fine needle aspiration (RPFNA) for correlational studies

Exclusion Criteria:

  • women who have been on raloxifene, tamoxifen, letrozole, anastrozole or exemestane within the six months prior to RPFNA.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00329017

United States, Kansas
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160
Sponsors and Collaborators
Carol Fabian, MD
Intergenetics, Inc.
Principal Investigator: Carol J Fabian, MD University of Kansas Medical Center
  More Information

Responsible Party: Carol Fabian, MD, Professor, Director Breast Cancer Prevention Unit, University of Kansas Medical Center Identifier: NCT00329017     History of Changes
Other Study ID Numbers: 9814
Study First Received: May 19, 2006
Last Updated: February 13, 2017
Individual Participant Data  
Plan to Share IPD: No
Plan Description: Global results will be published.

Keywords provided by University of Kansas Medical Center:
single nucleotide polymorphism
breast atypia
breast epithelial hyperplasia
high risk for breast cancer

Additional relevant MeSH terms:
Breast Neoplasms
Neoplasms by Site
Breast Diseases
Skin Diseases processed this record on April 27, 2017